Screener
Tarsus Pharmaceuticals, Inc. TARS Security deposits
Security deposits at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SecurityDepositLiability.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s security deposits?
- Tarsus Pharmaceuticals, Inc. (TARS) reported security deposits of $2M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s security deposits changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s security deposits decreased by 23.1% year-over-year, from $2.6M to $2M.
- What does security deposits mean?
- This metric tracks the cash or equivalent collateral held by the company as security against potential lease defaults or property damage by tenants. It represents a liability that must be returned upon the expiration of the lease, provided all contractual obligations are met.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s security deposits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude